Ardent Health Partners, Inc. (ARDT)
NYSE: ARDT · Real-Time Price · USD
16.44
-0.20 (-1.20%)
Nov 20, 2024, 4:00 PM EST - Market closed
Ardent Health Partners Revenue
Ardent Health Partners had revenue of $1.45B in the quarter ending September 30, 2024, with 5.92% growth. This brings the company's revenue in the last twelve months to $5.71B, up 11.23% year-over-year. In the year 2023, Ardent Health Partners had annual revenue of $5.41B with 5.45% growth.
Revenue (ttm)
$5.71B
Revenue Growth
+11.23%
P/S Ratio
0.41
Revenue / Employee
$248,079
Employees
23,000
Market Cap
2.35B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 5.41B | 279.80M | 5.45% |
Dec 31, 2022 | 5.13B | 259.29M | 5.32% |
Dec 31, 2021 | 4.87B | 708.52M | 17.02% |
Dec 31, 2018 | 4.16B | 1.16B | 38.79% |
Dec 31, 2017 | 3.00B | 897.06M | 42.68% |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2004 | Pro | Pro | Pro |
Dec 31, 2003 | Pro | Pro | Pro |
Dec 31, 2002 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Privia Health Group | 1.72B |
iRhythm Technologies | 560.03M |
Catalyst Pharmaceuticals | 460.48M |
Protagonist Therapeutics | 323.80M |
Twist Bioscience | 312.97M |
LeMaitre Vascular | 213.03M |
Iovance Biotherapeutics | 90.86M |
Arrowhead Pharmaceuticals | 19.65M |
ARDT News
- 5 days ago - Nine Ardent Health Facilities Earn “A” Hospital Safety Grade From The Leapfrog Group - Business Wire
- 14 days ago - Ardent Health Reports Third Quarter 2024 Results - Business Wire
- 15 days ago - Ardent Health to Participate in Upcoming Investor Conferences - Business Wire
- 27 days ago - Ardent Health Announces Third Quarter 2024 Results Conference Call and Webcast Date - Business Wire
- 6 weeks ago - Ardent Health Partners With Qventus to Drive Strategic Perioperative Growth - Business Wire
- 7 weeks ago - Ardent Health Added to Russell 2000® and 3000® Indexes - Business Wire
- 2 months ago - Ardent Health Completes Term Loan Repricing - Business Wire
- 2 months ago - Ardent Health Appoints Dave Styblo to Lead Investor Relations - Business Wire